EC Number |
BRENDA No. |
Title |
Journal |
Volume |
Pages |
Year |
Organism |
PubMed ID |
---|
2.3.1.22 | 758472 |
Discovery of human intestinal MGAT inhibitors using high-throughput mass spectrometry |
SLAS Discov. |
22 |
360-365 |
2017 |
Homo sapiens |
28328319 |
2.3.1.22 | 757379 |
Hepatic monoacylglycerol acyltransferase 1 is induced by prolonged food deprivation to modulate the hepatic fasting response |
J. Lipid Res. |
60 |
528-538 |
2019 |
Mus musculus |
30610082 |
2.3.1.22 | 756729 |
Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high-fat diet |
FEBS Open Bio |
10 |
316-326 |
2020 |
Homo sapiens |
31837122 |
2.3.1.22 | 756729 |
Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high-fat diet |
FEBS Open Bio |
10 |
316-326 |
2020 |
Mus musculus |
31837122 |
2.3.1.22 | 756081 |
Membrane topology of human monoacylglycerol acyltransferase-2 and identification of regions important for its localization to the endoplasmic reticulum |
Biochim. Biophys. Acta |
1861 |
1192-1204 |
2016 |
Homo sapiens |
27373844 |
2.3.1.22 | 757377 |
Metabolic importance of adipose tissue monoacylglycerol acyltransferase 1 in mice and humans |
J. Lipid Res. |
59 |
1630-1639 |
2018 |
Mus musculus |
29853530 |
2.3.1.22 | 757377 |
Metabolic importance of adipose tissue monoacylglycerol acyltransferase 1 in mice and humans |
J. Lipid Res. |
59 |
1630-1639 |
2018 |
Homo sapiens |
29853530 |
2.3.1.22 | 755776 |
Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo |
Anal. Biochem. |
524 |
68-75 |
2017 |
Homo sapiens |
27665677 |
2.3.1.22 | 757542 |
Metabolism of sn-1(3)-monoacylglycerol and sn-2-monoacylglycerol in caecal enterocytes and hepatocytes of brown trout (Salmo trutta) |
Lipids |
52 |
61-71 |
2017 |
Salmo trutta |
27873162 |
2.3.1.22 | 757403 |
Monoacylglycerol acyltransferase 2 (MGAT2) inhibitors for the treatment of metabolic diseases and nonalcoholic steatohepatitis (NASH) |
J. Med. Chem. |
61 |
9879-9888 |
2018 |
Homo sapiens |
29986142 |